Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: A prospective randomized study

Journal of Cardiac Surgery

Volumn 13, Issue 1, 1998, Pages 11-17

  Sirivella, Srikrishna ^a,b   Gielchinsky, Isaac ^a   Parsonnet, Victor ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^b Department of Cardiovascular and Thoracic Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL;

ADULT; AGED; AORTA BALLOON; ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART OUTPUT; HEART SURGERY; HUMAN; INOTROPISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 0032406502     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1998.tb01047.x     Document Type: Article

References (22)

1. Giles TD, Katz R, Sullivan JM, et al: Short and long acting angiotensin-converting enzyme inhibitors. A randomized-trial of lisinopril versus captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989;13:1240-1247.
2. Deedwania PC: Angiotensin converting enzyme inhibitors in congestive heart failure. Arch Intern Med 1990;150:1798-1805.
3. Francis GS: The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J. 1989;118 (3):642-648.
4. Brunner HR: The renin angiotensin system in hypertension: An update. Hosp Pract 1990;15:71-81.
5. Osterziel KJ, Dietz R, Schmid W, et al: Ace inhibition improves vagal reactivity in patients with heart failure. Am Heart J 1990;120(5):1120-1129.
6. Cody RJ: Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failure. Am J Cardiol 1990;66: 7D-13D.
7. Cohn JN: Mechanisms in heart failure and the role of angiotensin converting enzyme inhibition. Am J Cardiol 1990;66:2D-6D.
8. Sonnenblick EH, LeJemtel TH: Pathophysiology of congestive heart failure: Role of angiotensin converting enzyme inhibitors. Am J Med 1989;87(6B): 6B88S-6B91S.
9. Cheng TO: Congestive heart failure in coronary artery disease. Am J Med 1991;91:409-415.
10. Hirsch AT, Pint YM, Schumkert H, et al: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 1990;66:22D-32D.
11. Three new ACE inhibitors for hypertension. Med Lett 1991;33(852):83-84.
12. Suki WN: Renal hemodynamic consequences of angiotensin converting enzyme inhibition in congestive heart failure. Arch Int Med 1989;149:669-673.
13. Massie BM: All patients with left ventricular systolic dysfunction should be treated with an angiotensin converting enzyme inhibitor: A protagonist's viewpoint. Am J Cardiol 1990;66:439-443.
14. Crozier IG, Teoh R, Kay R, et al: Sympathetic nervous system during converting enzyme inhibition. Am J Med 1991;87(6B):6B29S-6B32S.
15. Kubo SH: Neurohormonal activation and the response to converting enzyme inhibition in congestive heart failure. Circulation 1990;81(Suppl III):III-107-III-114.
16. Faxon DP, Creager MA, Halperin JL, et al: Redistribution of regional blood flow following angiotensin converting enzyme inhibition: Comparison of normal subjects and patients with heart failure. Am J Med 1984;77:104-110.
17. Kiowoski W, Zuber M, Elsmer S, et al: Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure. Am Heart J 1991;122(5): 1382-1388.
18. Patel B, Kloner RA, Przyklenk K, et al: Post ischemic myocardial "stunning" a clinically relevant phenomenon. Ann Int Med 1988;108:626-628.
19. Cohn JN: Future directions in vasodilator therapy for heart failure. Am Heart J 1991;121(3):969-974.
20. Myers BD, Deen WM, Brenner BM: The effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 1975; 37:101-110.
21. Dzau VJ, Colucci WS, Williams GH, et al: Sustained effectiveness of converting enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 1980;302:1373-1379.
22. Stevenson RN, Keywood C, Amadi AA, et al: Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure. Br Heart J 1991;66:19-21.